En forma de pastilla, se espera que lleguen a Europa a finales de 2026 o principios de 2027 las pastillas de Wegovy y el medicamento Foundayo, con el ingrediente activo orfoglipron
Over the past ten years, GLP-1 receptor agonists (GLP-1RAs) such as Ozempic, Wegovy, and Mounjaro have taken the pharmaceutical world by storm
It is not for human consumption
It is more common in middle-aged and older adults
Many of our patients come to us through referrals and continue their care because they value the time, attention, and consistency they receive
Women of childbearing potential should use reliable contraception if they receive GLP-1 agonists, given the potential risks to fetal development (48)